Author:
Basto Pamela A.,Reticker-Flynn Nathan E.
Funder
Society for Immunotherapy of Cancer
METAvivor
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference66 articles.
1. Hutchinson L, Kirk R (2011) New paradigms to explain metastasis. Nat Rev Clin Oncol 8(6):313. https://doi.org/10.1038/nrclinonc.2011.68
2. Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541–550. https://doi.org/10.1038/s41591-018-0014-x
3. Hebert JD, Neal JW, Winslow MM (2023) Dissecting metastasis using preclinical models and methods. Nat Rev Cancer 23(6):391–407. https://doi.org/10.1038/s41568-023-00568-4
4. Amin MBE, S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR (2017) AJCC Cancer Staging Manual, 8th edn. Springer: American Joint Commission on Cancer
5. von Andrian UH, Mempel TR (2003) Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3(11):867–878. https://doi.org/10.1038/nri1222